HLA-B and COVID-19: In terms of SARS-CoV-2, an in silico study has found that individuals with HLA-B*46:01 variants may be susceptible to COVID-19, whereas HLA-B*15:03 represents a protective variant since it could provide T-cell based immunity [54].